Why the study?
Does mitral valve repair improve long-term survival and reduce valve-related morbidity compared to mitral valve replacement in children and young adults with rheumatic heart disease?
Does mitral valve repair improve long-term survival and reduce valve-related morbidity compared to mitral valve replacement in children and young adults with rheumatic heart disease?
In children and young adults with rheumatic heart disease, mitral valve repair offers superior long-term freedom from thromboembolic and hemorrhagic events and a trend toward better survival compared to valve replacement.
Answers are grounded in this paper and cite their sources.
May favor repair to reduce events in young rheumatic patients; hypothesis-generating and should not yet change practice without RCTs.
BACKGROUND: Mitral valve (MV) repair offers potential advantages over replacement in patients with rheumatic heart disease (RHD). We present the first long-term study that compares MV repair with replacement in children with RHD. METHODS AND RESULTS: Single institute retrospective review of patients with RHD under 20 years of age, who underwent their first isolated MV surgery between 1990 and 2006. Of the 81 patients, 98% were Māori or Pacific Islander. The median age was 12.7 (3-19) years. The MV was repaired in 59%, a mechanical valve replacement (MVR) took place in 35% and bioprosthetic valve replacement in 6% of the patients. Follow-up data were available for 91.4% of the patients with mean follow-up of 7.6 years (range 0-19.4 years), a total of 620 patient years. Actuarial survival at 10 and 14 years for patients with MVR was 79% and 44%, compared to 90% and 90% for patients who underwent repair (P = .06). Actuarial freedom from late reoperation at 10 and 14 years for patients with MVR was 88% and 73%, compared to 76% and 76% for patients with repair (P = .52). Actuarial freedom from thrombotic, embolic, and hemorrhagic events at 10 and 14 years for patients with MVR was 63% and 45%, compared to 100% and 100% for patients with repair P < .01). CONCLUSION: This study shows that MV repair is superior to replacement for RHD in the young with follow-up to 19 years. Repair offers a survival advantage, greater freedom from valve-related morbidity, and long-term durability that equals that of MVR.
No takes yet. Share an insight, caveat, or question.
Reményi et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: